Design of novel soft corticosteroids.
Bodor
N
N
Center for Drug Discovery, University of Florida, Gainesville.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D000734:Androstenediols / Q000378:metabolism; D000818:Animals; D004285:Dogs; D015195:Drug Design; D004341:Drug Evaluation; D006801:Humans; D006868:Hydrolysis; D008658:Inactivation, Metabolic; D000069559:Loteprednol Etabonate; D008958:Models, Molecular; D015394:Molecular Structure; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship
D000305:Adrenal Cortex Hormones; D000730:Androstadienes; D000734:Androstenediols; C026548:cortienic acid; D000069559:Loteprednol Etabonate